Pagoni M, Zogopoulos V, Kontogiannis S, Tsolakou A, Zoumpourlis V, Tsangaris G
Cancer Genomics Proteomics. 2025; 22(2):285-305.
PMID: 39993800
PMC: 11880924.
DOI: 10.21873/cgp.20502.
Duan L, Wang C, Li Y, Yang B, Zheng X, Liu J
Anal Bioanal Chem. 2024; 416(29):6839-6847.
PMID: 39400577
DOI: 10.1007/s00216-024-05580-7.
Devine J, Tadrous M, Hernandez I, Callaway Kim K, Rothenberger S, Mukhopadhyay N
J Am Heart Assoc. 2023; 13(1):e032266.
PMID: 38156554
PMC: 10863811.
DOI: 10.1161/JAHA.123.032266.
Wichitnithad W, Nantaphol S, Noppakhunsomboon K, Rojsitthisak P
Saudi Pharm J. 2023; 31(2):295-311.
PMID: 36942272
PMC: 10023554.
DOI: 10.1016/j.jsps.2022.12.010.
Szukalska M, Fraczyk T, Florek E, Paczek L
Molecules. 2023; 28(2).
PMID: 36677686
PMC: 9862342.
DOI: 10.3390/molecules28020628.
Does the Red Shift in UV-Vis Spectra Really Provide a Sensing Option for Detection of -Nitrosamines Using Metalloporphyrins?.
Trampuz M, Znidaric M, Gallou F, casar Z
ACS Omega. 2023; 8(1):1154-1167.
PMID: 36643536
PMC: 9835193.
DOI: 10.1021/acsomega.2c06615.
Angiotensin II receptor blockers (ARBs) and manufacturing contamination: A retrospective National Register Study into suspected associated adverse drug reactions.
Salim H, Jones A
Br J Clin Pharmacol. 2022; 88(11):4812-4827.
PMID: 35585835
PMC: 9796460.
DOI: 10.1111/bcp.15411.
Utilization of Generic Cardiovascular Drugs in Medicare's Part D Program.
Ma I, Tisdale R, Vail D, Heidenreich P, Sandhu A
Circ Cardiovasc Qual Outcomes. 2021; 14(12):e007559.
PMID: 34879702
PMC: 9070108.
DOI: 10.1161/CIRCOUTCOMES.120.007559.
Extent of a valsartan drug shortage and its effect on antihypertensive drug use in the Canadian population: a national cross-sectional study.
Fenna J, Chu C, Hassan R, Gomes T, Tadrous M
CMAJ Open. 2021; 9(4):E1128-E1133.
PMID: 34876414
PMC: 8673482.
DOI: 10.9778/cmajo.20200232.
Identification and Development of Therapeutics for COVID-19.
Rando H, Wellhausen N, Ghosh S, Lee A, Dattoli A, Hu F
mSystems. 2021; 6(6):e0023321.
PMID: 34726496
PMC: 8562484.
DOI: 10.1128/mSystems.00233-21.
Impact of national valsartan recalls on Veterans' outcomes.
Morizio P, Britnell S, Ottman A
Ther Adv Drug Saf. 2021; 12:20420986211016173.
PMID: 34249328
PMC: 8239958.
DOI: 10.1177/20420986211016173.
Development of a Sensitive Headspace Gas Chromatography-Mass Spectrometry Method for the Simultaneous Determination of Nitrosamines in Losartan Active Pharmaceutical Ingredients.
Wichitnithad W, Sudtanon O, Srisunak P, Cheewatanakornkool K, Nantaphol S, Rojsitthisak P
ACS Omega. 2021; 6(16):11048-11058.
PMID: 34056258
PMC: 8153937.
DOI: 10.1021/acsomega.1c00982.
Identification and Development of Therapeutics for COVID-19.
Rando H, Wellhausen N, Ghosh S, Lee A, Dattoli A, Hu F
ArXiv. 2021; .
PMID: 33688554
PMC: 7941644.
Impact of angiotensin receptor blocker product recalls on antihypertensive prescribing in Germany.
Rudolph U, Enners S, Kieble M, Mahfoud F, Bohm M, Laufs U
J Hum Hypertens. 2020; 35(10):903-911.
PMID: 33057175
PMC: 8502678.
DOI: 10.1038/s41371-020-00425-z.
Should Angiotensin-Converting Enzyme Inhibitors ever Be Used for the Management of Hypertension?.
Turner J, Kodali R
Curr Cardiol Rep. 2020; 22(9):95.
PMID: 32648000
PMC: 7344347.
DOI: 10.1007/s11886-020-01352-8.
Angiotensin Receptor Blockers and the Risk of Cancer: Insights from Clinical Trials and Recent Drug Recalls.
Berrido A, Byrd J
Curr Hypertens Rep. 2020; 22(3):20.
PMID: 32114653
DOI: 10.1007/s11906-020-1021-0.
Changes in Utilization of Generic Angiotensin Receptor Blockers Following Product Recalls in the United States.
Desai R, Sarpatwari A, Gautam N, Lii J, Fischer M, Gagne J
JAMA. 2020; 323(1):87-89.
PMID: 31910271
PMC: 6990815.
DOI: 10.1001/jama.2019.17521.
Antihypertensive agents: a long way to safe drug prescribing in children.
Siddiqi N, Shatat I
Pediatr Nephrol. 2019; 35(11):2049-2065.
PMID: 31676933
PMC: 7515858.
DOI: 10.1007/s00467-019-04314-7.
Current Status of Angiotensin Receptor Blocker Recalls.
Gunasekaran P, Chertow G, Bhalla V, Byrd J
Hypertension. 2019; 74(6):1275-1278.
PMID: 31630573
PMC: 7021211.
DOI: 10.1161/HYPERTENSIONAHA.119.13955.
